|
10107
|
Hecolin (Hepatitis vaccine -239)
|
Hepatitis E
|
Hepatitic
|
Hepatitis E virus
|
double stranded DNA
|
Virus like particle
|
Approved
|
Xiamen Innovax Biotech
|
2011
|
China
|
NA
|
3 doses at regimen of 0, 1, and 6 months
|
Intramuscular
|
NA
|
HEV-1 Chinese strain
|
NA
|
China FDA
|
NA
|
NA
|
NA
|
27610014
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988308/
|
https://www.precisionvaccinations.com/vaccines/hecolin-hepatitis-e-vaccine
|
|
10108
|
Hecolin (Hepatitis vaccine -239)
|
Hepatitis E
|
Hepatitic
|
Hepatitis E virus
|
double stranded DNA
|
Recombinant viral vector
|
Approved
|
Xiamen Innovax Biotech
|
2011
|
China
|
NA
|
3 doses at regimen of 0, 1, and 6 months
|
Intramuscular
|
Aluminum (aluminium hydroxide)
|
Capsid Protein ORF2
|
NA
|
China FDA
|
NA
|
NA
|
Hecolin
|
29546064
|
NCT01014845
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818934/
|
https://www.precisionvaccinations.com/vaccines/hecolin-hepatitis-e-vaccine
|
|
10296
|
rHEV
|
Hepatitis E
|
Hepatitic
|
Hepatitis E virus
|
double stranded DNA
|
Recombinant viral vector
|
Phase 2
|
GlaxoSmithKline
|
2011
|
USA
|
18 - 58 years
|
3 doses at regimen of 0, 1, and 6 months
|
NA
|
Aluminum (alum)
|
Capsid Protein ORF2
|
NA
|
NA
|
National Institute of Health, Novavax
|
NA
|
NA
|
NA
|
NA
|
https://www.who.int/immunization/sage/meetings/2014/october/4_Hepatitis_E_vaccine_pipeline_final_29_Sept_14.pdf
|
NA
|